DEBT SETTLEMENT AGREEMENTDebt Settlement Agreement • February 17th, 2015 • Propanc Health Group Corp • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 17th, 2015 Company Industry JurisdictionThis Settlement Agreement and Release Agreement (“Agreement”) is entered into as of February 4, 2015 (the “Effective Date”), by and between Propanc Health Group Corporation, a Delaware corporation with an address at Level 13, Suite 1307, 530 Collins St., Melbourne, VIC, 3000 Australia (“Propanc”) and Propanc PTY Ltd., an Australian limited company (“Porpanc PTY”) (Propanc and Propanc PTY shall be collectively referred to herein as “Company”) and Julian Kenyon, a director of the Company (the “Director”). Company and Director are referred to in this Agreement individually as the “Party” or collectively as the “Parties.”
DEBT SETTLEMENT AGREEMENTDebt Settlement Agreement • February 17th, 2015 • Propanc Health Group Corp • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 17th, 2015 Company Industry JurisdictionThis Settlement Agreement and Release Agreement (“Agreement”) is entered into as of February 4, 2015 (the “Effective Date”), by and between Propanc Health Group Corporation, a Delaware corporation with an address at Level 13, Suite 1307, 530 Collins St., Melbourne, VIC, 3000 Australia (“Propanc”) and Propanc PTY Ltd., an Australian limited company (“Porpanc PTY”) (Propanc and Propanc PTY shall be collectively referred to herein as “Company”) and James Nathanielsz, a director of the Company (the “Director”). Company and Director are referred to in this Agreement individually as the “Party” or collectively as the “Parties.”